Advertisement


Rent Increase Survey

Have you submitted your latest rent increase data to the rent increase survey?

BioTime Promotes COO Adi Mohanty to Co-CEO Role

BioTime of Alameda has appointed Adi Mohanty as co-CEO. (LinkedIn)

BioTime, Inc., of Alameda, announced today that it has appointed Chief Operating Officer Adi Mohanty as co-Chief Executive Officer, serving with Michael West, PhD.

[…]

Continue reading…

BioTime Appoints Adi Mohanty Chief Operating Officer

BioTime of Alameda has appointed Adi Mohanty Chief Operating Officer. (LinkedIn)

BioTime, a bio-technology research and product development company based in Alameda, announced yesterday that it has appointed Adi Mohanty as Chief Operating Officer.

[…]

Continue reading…

Alameda’s BioTime to Raise $9 million in Capital

BioTime is raising $9 million through a registered direct offering. (Google Street View)

Alameda’s BioTime, Inc. announced this week that it intends to raise $9 million through the sale of some 2 million common shares and 545,000 warrants in a registered direct offering.

[…]

Continue reading…

BioTime Inks Deal With Geron for Stem Cell Assets

BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View)

BioTime, Inc., an Alameda-based biotechnology company, announced today that it has signed a deal with Geron Corporation to acquire intellectual property and other assets related to human embryonic stem cell programs from […]

Continue reading…

BioTime Moves Forward on Stem Cell Asset Acquisition

BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View)

Alameda biotech firm BioTime announced late yesterday that it is making progress on its efforts to acquire stem cell research and development assets from Geron Corporation of Menlo Park.

[…]

Continue reading…

BioTime Tries to Woo Geron Shareholders

BioTime of Alameda has made a bid for stem cell research assets owned by Geron Corporation.

Alameda’s BioTime has issued an open letter to shareholders of Geron Corporation, encouraging them to support a $53 million deal that would see a BioTime subsidiary acquire stem cell research and development assets from Geron.

[…]

Continue reading…

BioTime of Alameda Reports Financial Results

BioTime, a biotech company based in Alameda announced second quarter financial results yesterday. For the quarter ended June 30, 2012, the company realized a net loss of $5.5 million or $0.11 per share. For the first six months of this year, the company reported a loss of $10.4 million, worse than the $7.6 million loss […]

Continue reading…

BioTime to Market Stem Cells in China, Taiwan

BioTime, an Alameda-based biotechnology company, announced this week that it will market its stem cell lines in Asia, through an agreement with Shanghai Genext Medical Technology Company.

[…]

Continue reading…

BioTime Expands Alameda Headquarters

BioTime Inc., a biotech company based in Alameda’s Harbor Bay Business Park, is expanding their corporate headquarters.

[…]

Continue reading…

  • Alameda Municipal Power Rates to Increase Again https://t.co/JkSSgBuZD0 ,
  • Alameda Municipal Power Rates to Increase Again https://t.co/JkSSgBuZD0 ,
  • Alameda Municipal Power Rates to Increase Again https://t.co/JkSSgBuZD0 ,
  • Alameda Municipal Power Rates to Increase Again https://t.co/JkSSgBuZD0 ,
  • Unique Island City in San Francisco Bay area: City of Alameda, California https://t.co/wuoBPF6eYe ,

Directories